NASDAQ:ATRI - ATRION Stock Price, Price Target & More

Get Started

$594.45 -2.40 (-0.40 %)

(As of 05/20/2018 04:00 PM ET)

Previous Close$594.45

Today's Range$593.00 - $596.00

52-Week Range$516.85 - $694.00

Volume4,002 shs

Average Volume7,819 shs

Market Capitalization$1.10 billion

P/E Ratio31.44

Dividend Yield0.81%

Beta0.67

About ATRION (NASDAQ:ATRI)

Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise MPS2 myocardial protection system that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products that are used in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measures the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers, as well as other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Receive ATRI News and Ratings via Email

Sign-up to receive the latest news and ratings for ATRI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments

Sub-IndustryHealth Care Supplies

SectorMedical

SymbolNASDAQ:ATRI

CUSIP04990410

Webwww.atrioncorp.com

Phone972-390-9800

Debt

Debt-to-Equity RatioN/A

Current Ratio9.62

Quick Ratio6.95

Price-To-Earnings

Trailing P/E Ratio31.44

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$146.60 million

Price / Sales7.50

Cash Flow$23.2207 per share

Price / Cash25.60

Book Value$103.12 per share

Price / Book5.76

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$36.59 million

Net Margins23.82%

Return on Equity19.34%

Return on Assets17.32%

Miscellaneous

Employees528

Outstanding Shares1,850,000

ATRION (NASDAQ:ATRI) Frequently Asked Questions

What is ATRION's stock symbol?

ATRION trades on the NASDAQ under the ticker symbol "ATRI."

How often does ATRION pay dividends? What is the dividend yield for ATRION?

ATRION declared a quarterly dividend on Wednesday, February 28th. Stockholders of record on Thursday, March 15th will be paid a dividend of $1.20 per share on Friday, March 30th. This represents a $4.80 annualized dividend and a dividend yield of 0.81%. The ex-dividend date of this dividend is Wednesday, March 14th. View ATRION's Dividend History.

How were ATRION's earnings last quarter?

ATRION Co. (NASDAQ:ATRI) posted its earnings results on Tuesday, February, 27th. The medical instruments supplier reported $4.66 earnings per share for the quarter. The medical instruments supplier earned $34.02 million during the quarter. ATRION had a net margin of 23.82% and a return on equity of 19.34%. View ATRION's Earnings History.

When is ATRION's next earnings date?

ATRION is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for ATRION.

Who are some of ATRION's key competitors?

Some companies that are related to ATRION include Merit Medical Systems (MMSI), NovoCure (NVCR), NuVasive (NUVA), Nevro (NVRO), iRhythm (IRTC), Mazor Robotics (MZOR), Luminex (LMNX), Glaukos (GKOS), Intersect ENT (XENT), Orthofix (OFIX), Cardiovascular Systems (CSII), OraSure Technologies (OSUR), CryoLife (CRY), K2M Group (KTWO) and Cerus (CERS).

Who are ATRION's key executives?

ATRION's management team includes the folowing people:

Mr. Emile A. Battat, Exec. Chairman (Age 80)
Mr. David A. Battat, Pres & CEO (Age 48)
Mr. Jeffery Strickland, VP, CFO, Sec., Treasurer & Principal Accounting Officer (Age 59)

Has ATRION been receiving favorable news coverage?

News articles about ATRI stock have trended somewhat negative this week, according to Accern. The research firm identifies positive and negative press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. ATRION earned a media sentiment score of -0.08 on Accern's scale. They also assigned news coverage about the medical instruments supplier an impact score of 44.43 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Who are ATRION's major shareholders?

ATRION's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Neuberger Berman Group LLC (5.51%), BlackRock Inc. (5.05%), Dimensional Fund Advisors LP (3.40%), Northern Trust Corp (1.18%), Thomson Horstmann & Bryant Inc. (0.84%) and Schwab Charles Investment Management Inc. (0.40%). Company insiders that own ATRION stock include Emile A Battat, Hugh J Morgan Jr, Jeffery Strickland and Roger F Stebbing. View Institutional Ownership Trends for ATRION.

Which major investors are selling ATRION stock?

ATRI stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Thomson Horstmann & Bryant Inc., Citigroup Inc., SG Americas Securities LLC, Morgan Dempsey Capital Management LLC, Dimensional Fund Advisors LP, Thrivent Financial for Lutherans and JPMorgan Chase & Co.. View Insider Buying and Selling for ATRION.

Which major investors are buying ATRION stock?

ATRI stock was bought by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, Millennium Management LLC, Northern Trust Corp, UBS Group AG, Piermont Capital Management Inc., A.R.T. Advisors LLC, Rhumbline Advisers and Schwab Charles Investment Management Inc.. View Insider Buying and Selling for ATRION.

How do I buy shares of ATRION?

Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ATRION's stock price today?

One share of ATRI stock can currently be purchased for approximately $594.45.

How big of a company is ATRION?

ATRION has a market capitalization of $1.10 billion and generates $146.60 million in revenue each year. ATRION employs 528 workers across the globe.

How can I contact ATRION?

ATRION's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The medical instruments supplier can be reached via phone at 972-390-9800 or via email at [email protected]

MarketBeat Community Rating for ATRION (ATRI)

Community Ranking:		2.2 out of 5 ( )
Outperform Votes:		48 (Vote Outperform)
Underperform Votes:		59 (Vote Underperform)
Total Votes:		107

MarketBeat's community ratings are surveys of what our community members think about ATRION and other stocks. Vote "Outperform" if you believe ATRI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATRI will underperform the S&P 500 over the long term. You may vote once every thirty days.

ATRION (NASDAQ:ATRI) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	N/A	N/A	N/A	N/A
Consensus Rating Score:	N/A	N/A	N/A	N/A
Ratings Breakdown:	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	N/A	N/A	N/A	N/A
Price Target Upside:	N/A	N/A	N/A	N/A

ATRION (NASDAQ:ATRI) Consensus Price Target History

Price Target History for ATRION (NASDAQ:ATRI)

ATRION (NASDAQ:ATRI) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
6/15/2016	BWS Financial	Reiterated Rating	Sell		N/A

(Data available from 5/20/2016 forward)

ATRION (NASDAQ:ATRI) Earnings History and Estimates Chart

Earnings by Quarter for ATRION (NASDAQ:ATRI)

ATRION (NASDAQ ATRI) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/6/2018							N/A
2/27/2018	Q4 2017		$4.66		$34.02 million	View	N/A
11/8/2017	Q3 2017		$4.29		$37.90 million	View	N/A
8/8/2017	Q2 2017		$5.40		$36.16 million	View	N/A
5/10/2017	Q1 2017		$4.14		$38.50 million	View	N/A
2/23/2017	Q4		$3.00		$33.29 million	View	N/A
11/3/2016	Q3 2016		$4.10		$37.84 million	View	N/A
8/9/2016	Q2		$4.02	$37.70 million	$36.10 million	View	N/A
5/4/2016	Q1 2016		$3.76		$36.22 million	View	N/A
2/22/2016	Q4		$3.27	$229.80 million	$267.50 million	View	N/A
11/5/2015	Q3 2015		$4.19		$37.38 million	View	N/A
8/4/2015	Q115		$3.99	$35.03 million	$37.66 million	View	N/A
5/6/2015	Q1 2015		$4.01		$38.32 million	View	N/A
2/23/2015	Q414		$3.08	$31.90 million	$32.70 million	View	N/A
10/31/2014	Q3 2014		$3.91		$36.63 million	View	N/A
8/6/2014	Q2 2014		$3.48		$35.03 million	View	N/A
5/5/2014	Q114		$3.61	$33.49 million	$36.42 million	View	N/A
2/24/2014	Q4 2013		$2.87		$31.85 million	View	N/A
10/29/2013	Q3 2013		$3.81		$34.04 million	View	N/A
7/31/2013	Q2 2013		$3.22		$32.61 million	View	N/A
5/9/2013	Q1 2013		$3.28		$33.49 million	View	N/A
2/19/2013	Q4 2012	$3.21	$2.42			View	N/A
11/7/2012	Q3 2012	$2.79	$3.59			View	N/A
8/7/2012	Q2 2012	$2.94	$3.02			View	N/A
5/8/2012	Q1 2012	$3.27	$2.65			View	N/A
2/21/2012	Q4 2011	$3.36	$2.65			View	N/A
11/2/2011	Q3 2011	$3.33	$3.33			View	N/A
8/4/2011	Q2 2011	$3.07	$3.46			View	N/A
5/9/2011	Q1 2011	$2.77	$3.38			View	N/A
2/18/2011	Q4 2010	$2.43	$2.63			View	N/A
11/4/2010	Q3 2010	$2.50	$2.66			View	N/A
8/4/2010	Q2 2010	$2.28	$2.67			View	N/A
5/6/2010	Q1 2010		$2.31			View	N/A
2/19/2010	Q4 2009		$1.78			View	N/A
11/4/2009	Q3 2009		$2.20			View	N/A
8/3/2009	Q2 2009		$2.30			View	N/A
5/7/2009	Q1 2009		$2.06			View	N/A
2/19/2009	Q4 2008		$1.94			View	N/A
11/6/2008	Q3 2008		$1.99			View	N/A
8/7/2008	Q2 2008		$2.06			View	N/A
5/8/2008	Q1 2008		$1.83			View	N/A
2/22/2008	Q4 2007		$1.57			View	N/A

(Earnings results data provided by Zacks Investment Research)

ATRION (NASDAQ:ATRI) Dividend Information

ATRION pays an annual dividend of $4.80 per share, with a dividend yield of 0.81%. ATRI's most recent quarterly dividend payment was Friday, March 30. The company has grown its dividend for the last 15 consecutive years and is increasing its dividend by an average of 17.40% each year.

Most Recent Dividend:	3/30/2018
Annual Dividend:	$4.80
Dividend Yield:	0.81%
Dividend Growth:	17.40% (3 Year Average)
Payout Ratio(s):	20.67% (Based on Cash Flow) N/A
Track Record:	15 Years of Consecutive Dividend Growth
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for ATRION (NASDAQ:ATRI)

ATRION (NASDAQ:ATRI) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/28/2018	quarterly	$1.20	0.82%	3/14/2018	3/15/2018	3/30/2018
11/9/2017	quarterly	$1.20	0.74%	11/30/2017	12/1/2017	12/15/2017
8/15/2017	quarterly	$1.20	0.77%	9/14/2017	9/15/2017	9/29/2017
5/24/2017	quarterly	$1.05	0.78%	6/13/2017	6/15/2017	6/30/2017
2/24/2017	quarterly	$1.05	0.86%	3/13/2017	3/15/2017	3/31/2017
11/11/2016	quarterly	$1.05	0.93%	11/29/2016	12/1/2016	12/15/2016
8/10/2016	quarterly	$1.05	0.94%	9/13/2016	9/15/2016	9/30/2016
5/25/2016	quarterly	$0.90	0.9%	6/13/2016	6/15/2016	6/30/2016
2/24/2016	quarterly	$0.90	0.95%	3/11/2016	3/15/2016	3/31/2016
11/16/2015	quarterly	$0.90	0.92%	11/27/2015	12/1/2015	12/15/2015
8/5/2015	quarterly	$0.90	0.9%	9/11/2015	9/15/2015	9/30/2015
5/22/2015	quarterly	$0.75	0.79%	6/11/2015	6/15/2015	6/30/2015
3/4/2015	quarterly	$0.75	0.93%	3/13/2015	3/17/2015	3/31/2015
11/14/2014	quarterly	$0.75	0.92%	11/26/2014	12/1/2014	12/15/2014
9/3/2014	quarterly	$0.75	0.93%	9/11/2014	9/15/2014	9/30/2014
5/22/2014	quarterly	$0.64	0.81%	6/12/2014	6/16/2014	6/30/2014
3/3/2014	quarterly	$0.64	0.83%	3/13/2014	3/17/2014	3/31/2014
11/7/2013	quarterly	$0.64	0.95%	11/27/2013	12/2/2013	12/16/2013
8/14/2013	quarterly	$0.64	1.03%	9/11/2013	9/13/2013	9/30/2013

(Data available from 1/1/2013 forward)

ATRION (NASDAQ ATRI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 22.46%
Institutional Ownership Percentage: 59.76%

Insider Trading History for ATRION (NASDAQ:ATRI)

Institutional Ownership by Quarter for ATRION (NASDAQ:ATRI)

ATRION (NASDAQ ATRI) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/6/2017	Emile A Battat	Chairman	Sell	1,408	$652.91	$919,297.28	148,881
6/9/2017	Emile A Battat	Chairman	Sell	100	$585.50	$58,550.00	149,081
6/6/2017	Emile A Battat	Chairman	Sell	699	$580.84	$406,007.16	149,480
6/2/2017	Emile A Battat	Chairman	Sell	1,217	$564.04	$686,436.68	150,797
5/26/2017	Emile A Battat	Chairman	Sell	655	$546.31	$357,833.05	151,297
5/17/2017	Emile A Battat	Chairman	Sell	721	$542.64	$391,243.44	152,112
12/19/2016	Jeffery Strickland	CFO	Sell	1,000	$509.60	$509,600.00
11/14/2016	Emile A Battat	Chairman	Sell	2,093	$452.87	$947,856.91	142,373
11/10/2016	Emile A Battat	Chairman	Sell	1,102	$443.01	$488,197.02	142,968
8/29/2016	Hugh J Morgan Jr	Director	Sell	2,021	$441.11	$891,483.31	19,942
8/12/2016	Roger F Stebbing	Director	Sell	784	$446.64	$350,165.76	6,150
6/23/2016	Emile A Battat	Chairman	Sell	12	$432.00	$5,184.00	143,868
6/22/2016	Emile A Battat	Chairman	Sell	72	$427.50	$30,780.00	143,880
6/21/2016	Emile A Battat	Chairman	Sell	1,091	$429.00	$468,039.00	144,617
6/20/2016	Emile A Battat	Chairman	Sell	426	$429.00	$182,754.00	144,617
6/17/2016	Jeffery Strickland	CFO	Sell	1,000	$425.28	$425,280.00
6/16/2016	Emile A Battat	Chairman	Sell	3,130	$423.21	$1,324,647.30	147,673
4/25/2016	Jeffery Strickland	CFO	Sell	1,100	$399.73	$439,703.00
3/24/2016	Jeffery Strickland	CFO	Sell	50	$380.24	$19,012.00
3/23/2016	Jeffery Strickland	CFO	Sell	400	$380.43	$152,172.00
3/18/2016	Jeffery Strickland	CFO	Sell	2	$390.00	$780.00

(Data available from 1/1/2013 forward)

ATRION (NASDAQ ATRI) News Headlines

Source:

Date	Headline
	ATRION (ATRI) Cut to "Strong Sell" at BidaskClub www.americanbankingnews.com - May 15 at 10:14 AM
	Oversold Conditions For Atrion (ATRI) www.nasdaq.com - May 14 at 3:55 PM
	Contrasting Obalon Therapeutics (OBLN) & ATRION (ATRI) www.americanbankingnews.com - May 12 at 1:39 PM
	ATRION Co. (ATRI) Given Average Rating of "Strong Sell" by Analysts www.americanbankingnews.com - May 12 at 5:37 AM
	BidaskClub Lowers ATRION (ATRI) to Sell www.americanbankingnews.com - May 10 at 1:03 PM
	Atrion Reports First Quarter Results finance.yahoo.com - May 10 at 10:27 AM
	Atrion: 1Q Earnings Snapshot finance.yahoo.com - May 10 at 10:27 AM
	Where Atrion Corporation (NASDAQ:ATRI) Stands In Terms Of Earnings Growth Against Its Industry finance.yahoo.com - May 8 at 3:54 PM
	ATRION (ATRI) versus Invuity (IVTY) Head-To-Head Review www.americanbankingnews.com - May 4 at 5:22 AM
	ATRION (ATRI) Scheduled to Post Earnings on Tuesday www.americanbankingnews.com - May 1 at 5:50 AM
	Analysts Set $300.00 Price Target for ATRION Co. (ATRI) www.americanbankingnews.com - April 27 at 1:06 AM
	ATRION (ATRI) Upgraded to Sell at BidaskClub www.americanbankingnews.com - April 21 at 7:06 AM
	BidaskClub Downgrades ATRION (ATRI) to Buy www.americanbankingnews.com - April 15 at 2:21 PM
	Zacks: ATRION Co. (ATRI) Given $300.00 Average Price Target by Brokerages www.americanbankingnews.com - April 12 at 9:51 AM
	ATRION (ATRI) Downgraded by BidaskClub to Strong Sell www.americanbankingnews.com - April 7 at 7:02 AM
	Atrion (ATRI) Downgraded by BidaskClub www.americanbankingnews.com - March 30 at 9:17 AM
	Atrion (ATRI) Upgraded to Sell by BidaskClub www.americanbankingnews.com - March 29 at 11:16 AM
	Zacks: Atrion Co. (ATRI) Given Average Rating of "Strong Sell" by Analysts www.americanbankingnews.com - March 27 at 9:26 AM
	Zacks: Atrion Co. (ATRI) Receives Average Rating of "Strong Sell" from Analysts www.americanbankingnews.com - March 12 at 7:58 PM
	Free Post Earnings Research Report: Mettler-Toledo’s Quarterly Earnings Increased 13.07% finance.yahoo.com - March 12 at 9:39 AM
	Atrion Corporation (NASDAQ:ATRI) Delivered A Better ROE Than The Industry, Here’s Why finance.yahoo.com - March 10 at 10:29 AM
	Atrion Co. (ATRI) Given Consensus Recommendation of "Strong Sell" by Analysts www.americanbankingnews.com - March 7 at 1:50 PM
	Atrion Co. (ATRI) Shares Bought by Raymond James Financial Services Advisors Inc. www.americanbankingnews.com - March 6 at 8:00 AM
	Atrion Co. (ATRI) Shares Sold by Morgan Dempsey Capital Management LLC www.americanbankingnews.com - March 3 at 3:53 PM
	Atrion Co. (ATRI) Given Consensus Recommendation of "Strong Sell" by Brokerages www.americanbankingnews.com - March 2 at 11:40 PM
	Atrion Co. (ATRI) Shares Sold by Martingale Asset Management L P www.americanbankingnews.com - March 2 at 12:16 PM
	Atrion (ATRI) Releases Quarterly Earnings Results www.americanbankingnews.com - March 1 at 11:18 AM
	Atrion Co. Announces Quarterly Dividend of $1.20 (ATRI) www.americanbankingnews.com - February 28 at 5:18 PM
	Atrion Reports 2017 Results for Fourth Quarter and Full Year finance.yahoo.com - February 28 at 10:10 AM
	American Century Companies Inc. Grows Holdings in Atrion Co. (ATRI) www.americanbankingnews.com - February 28 at 4:18 AM
	2,262 Shares in Atrion Co. (ATRI) Purchased by BancorpSouth Bank www.americanbankingnews.com - February 26 at 5:22 AM
	Should You Be Tempted To Buy Atrion Corporation (NASDAQ:ATRI) Because Of Its PE Ratio? finance.yahoo.com - February 21 at 4:08 PM
	Financial Survey: Ocular Therapeutix (OCUL) & Atrion (ATRI) www.americanbankingnews.com - February 20 at 5:16 AM
	Atrion (ATRI) Set to Announce Quarterly Earnings on Wednesday www.americanbankingnews.com - February 14 at 2:02 AM
	Analyzing Atrion (ATRI) & Its Competitors www.americanbankingnews.com - February 12 at 3:16 PM
	Financial Survey: Atrion (ATRI) and Its Rivals www.americanbankingnews.com - February 9 at 5:34 PM
	Comparing Atrion (ATRI) & The Competition www.americanbankingnews.com - February 8 at 9:04 AM
	Financial Analysis: Atrion (ATRI) & Its Competitors www.americanbankingnews.com - February 5 at 10:34 AM
	Atrion Co. (ATRI) Given Consensus Rating of "Strong Sell" by Brokerages www.americanbankingnews.com - February 3 at 11:18 PM
	Head-To-Head Contrast: Atrion (ATRI) versus Its Peers www.americanbankingnews.com - February 2 at 5:12 PM
	Head to Head Survey: Atrion (ATRI) versus Its Peers www.americanbankingnews.com - January 31 at 11:12 PM
	Analyzing Atrion (ATRI) and Its Competitors www.americanbankingnews.com - January 31 at 9:26 AM
	Head-To-Head Contrast: Atrion (ATRI) & Its Peers www.americanbankingnews.com - January 24 at 5:14 AM
	Atrion (ATRI) versus The Competition Critical Review www.americanbankingnews.com - January 19 at 8:30 AM
	Reviewing Atrion (ATRI) and Its Peers www.americanbankingnews.com - January 18 at 11:18 AM
	Atrion (ATRI) vs. Its Competitors Financial Contrast www.americanbankingnews.com - January 16 at 5:08 AM
	Contrasting Atrion (ATRI) & The Competition www.americanbankingnews.com - January 15 at 11:40 AM
	Comparing MiMedx Group (MDXG) and Atrion (ATRI) www.americanbankingnews.com - January 15 at 1:10 AM
	Comparing Atrion (ATRI) & Its Competitors www.americanbankingnews.com - January 14 at 1:08 AM
	Zacks: Atrion Co. (ATRI) Given Average Recommendation of "Strong Sell" by Analysts www.americanbankingnews.com - January 10 at 5:50 PM

ATRION (NASDAQ:ATRI) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

ATRION (NASDAQ:ATRI) Income Statement, Balance Sheet and Cash Flow Statement

ATRION (NASDAQ ATRI) Stock Chart for Sunday, May, 20, 2018

Loading chart…

This page was last updated on 5/20/2018 by MarketBeat.com Staff